Ginger, echinacea, and curcumin are just a few of the herbs that you may hear about when looking into natural remedies for chronic obstructive pulmonary disease (COPD) or other respiratory conditions.

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

COPD is a serious yet preventable disease, and early intervention can preserve lung function and overall well-being.

Most cases of COPD are linked to smoking, but other factors include inhaling pollutants like ammonia, asbestos and dust (archived here and here). The disease has no cure, but patients can improve ...

The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.

a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study included 20,388 propensity score-matched ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...